Evidence map›Paper›PMID 27098408›Full record

Observational studyAIDS and behavior2016

Validation of a New Three-Item Self-Report Measure for Medication Adherence.

Ira B Wilson, Yoojin Lee, Joanne Michaud, Floyd J Fowler, William H Rogers

8 registry-linked trialsOpen access · greenAbstract readComparative StudyObservational StudyValidation Study
In one paragraph

Observational study in AIDS and behavior, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 8 registered trials, which are not on this map. Cited by 222 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
222citing papers in PubMed, 8 pooled it
15.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03537872 nacompletednot on this mapstarted 2018, after this paper: background citation

PROvide MIner-friendly SErvices for Integrated TB/HIV Care in Lesotho Study (PROMISE Study)

TypeinterventionalSponsorColumbia UniversityRan2018 to 2019Enrolled248ConditionsHIVArmsMiner-Friendly (MF) Service Venues TB/HIV Integration Strategies, Public Sector (PS) Health Facilities TB/HIV Integration Strategies
NCT04097834 completednot on this mapstarted 2019, after this paper: background citation

Integrating PrEP Into Family Planning Services at Title X Clinics in the Southeastern US

TypeobservationalSponsorUniversity of North Carolina, Chapel HillRan2019 to 2022Enrolled103ConditionsHIV Infections
NCT04549259 nacompletednot on this mapstarted 2021, after this paper: background citation

Testing a Multi-Component Intervention to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV

TypeinterventionalSponsorMedical College of WisconsinRan2021 to 2022Enrolled61ConditionsHIVArmsGroup-Based Social Support, HIV Stigma Reduction, Strengths-Based Case Management (SBCM), Personalized Technology Detailing
NCT04758390 nacompletednot on this mapstarted 2021, after this paper: background citation

Multilevel Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women

TypeinterventionalSponsorUniversity of Illinois at ChicagoRan2021 to 2024Enrolled1,290ConditionsSexually Transmitted Infections, HIV InfectionsArmsIMARA (intervention group), Health promotion control group
NCT04982250 nacompletednot on this mapstarted 2022, after this paper: background citation

Peer PrEP Referral + HIV Self-test Delivery for PrEP Initiation Among Young Kenyan Women: Pilot Study & Randomized Trial

TypeinterventionalSponsorFred Hutchinson Cancer CenterRan2022 to 2024Enrolled211ConditionsHIV PreventionArmsEnhanced peer PrEP referral + HIVST delivery
NCT05886621 nacompletednot on this mapstarted 2023, after this paper: background citation

Pilot RCT to Test the Integrated mHealth App Intervention (SiS-H) for Smoking Cessation for People With HIV

TypeinterventionalSponsorMassachusetts General HospitalRan2023 to 2025Enrolled66ConditionsSmoking CessationArmsSmiling instead of Smoking - HIV, QuitGuide
NCT06159582 nacompletednot on this mapstarted 2024, after this paper: background citation

eSTEP: An Integrated mHealth Intervention to Engage High-risk Individuals Along the Full PrEP Care Continuum

TypeinterventionalSponsorSan Diego State UniversityRan2024 to 2025Enrolled113ConditionsPre-Exposure Prophylaxis (PrEP)ArmseSTEP, Usual Care
NCT06269081 narecruitingnot on this mapstarted 2024, after this paper: background citation

Testing the Efficacy of Two Interventions to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV

TypeinterventionalSponsorMedical College of WisconsinRan2024 to 2027Enrolled352ConditionsHIVArmsSupportive-Expressive Peer Social Support Group Intervention, Individual Strengths-Based Case Management Intervention
3 · Its place in the literature

Who cites it

222 citing papers in PubMed, 8 syntheses or guidelines pooled it, 318 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Validation of the PrEP Use Self-Efficacy (PrEP-Use) Scale Among Sexual Minority Men.AIDS education and prevention : official publication of the International Society for AIDS Education · 2025
    Trial
  18. Trial
  19. Trial
  20. Trial

162 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ira B WilsonDepartment of Health Services, Policy & Practice, Brown University School of Public Health, Box G-121-7, 121 South Main St., Providence, RI, 02912, USA. ira_wilson@brown.edu.
Yoojin LeeDepartment of Health Services, Policy & Practice, Brown University School of Public Health, Box G-121-7, 121 South Main St., Providence, RI, 02912, USA.
Joanne MichaudDepartment of Health Services, Policy & Practice, Brown University School of Public Health, Box G-121-7, 121 South Main St., Providence, RI, 02912, USA.
Floyd J FowlerCenter for Survey Research, University of Massachusetts, Boston, MA, USA.
William H RogersCenter for Health Solutions, Tufts Medical Center, Boston, MA, USA.
Brown University · USTufts Medical Center · USUniversity of Massachusetts Boston · US

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI LARRY K BROWN · 1998 to 2026
$51.7M
Improving the self-report of medication adherence problems in HIVR01MH092238 · NIMH · BROWN UNIVERSITY · PI WILSON, IRA B · 2010 to 2012
$1.1M
Improving the diagnosis and treatment of medication adherence problems in HIVK24MH092242 · NIMH · BROWN UNIVERSITY · PI WILSON, IRA B · 2010 to 2014
$937k
NIAID NIH HHS P30 AI042853NIMH NIH HHS K24 MH092242NIMH NIH HHS R01 MH092238
6 · The paper itself

Abstract

Few self-report measures of medication adherence have been rigorously developed and validated against electronic drug monitoring (EDM). Assess the validity of the 3-item self-report scale by comparing it with a contemporaneous EDM measure. We conducted an observational study in which adherence assessments were done monthly for up to 4 months for 81 patients with HIV who were taking antiretroviral medications. We report results for both HIV antiretroviral medications, and also for other, non-HIV-related medications. Raw and calibrated self-report adherence measures, electronic drug monitoring adherence measures, and sociodemographic variables. The mean age of patients was 46 years, 37 % were female, 49 % had some education beyond high school, 22 % were Black, and 22 % were Hispanic. Cronbach's alphas for the 3-item scale for HIV and non-HIV medications were 0.83 and 0.87, respectively. The mean differences (raw/uncalibrated self-report scale minus EDM) for HIV and non-HIV medications were 7.5 and 5.2 points on a 100-point scale (p < 0.05 for both). Pearson correlation coefficients between the calibrated 3-item scale and the EDM for HIV and non-HIV medications were 0.47 and 0.59, respectively. The c-statistics for the ROC curves for the calibrated scale, using cut-offs of 0.8 and 0.9 for the EDM gold standard measure to define non-adherence, were between 0.74 and 0.76 for HIV and non-HIV medications. This 3-item adherence self-report scale showed good psychometric characteristics and good construct validity when compared with an EDM standard, for both HIV and non-HIV medications. In clinical care it can be a useful first-stage screener for non-adherence. In clinical research and quality improvement settings it can be a useful tool when more complex and expensive methods such as EDM or pharmacy claims are impractical or unavailable.

Indexed as

Drug MonitoringElectronic Health RecordsSelf ReportSurveys and QuestionnairesAdultAnti-HIV AgentsDrug Therapy, CombinationFemaleHIV InfectionsHumansMaleMedication AdherenceMiddle AgedPsychometricsAnti-HIV AgentsHighly active antiretroviral therapyHIVMedication adherencePatient complianceSelf-report

Identifiers

PMID27098408
PMCPMC5071118
OpenAlexW2340311148

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

and 2 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.